menu
    • menu

    Company profile for Corcept Therapeutics

    NEW Drugs in Dev: 16
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    we are leading the discovery and development of drugs that modulate the effects of cortisol Cortisol dysregulation plays an important role in a variety of endocrine, metabolic, oncologic, psychiatric, and ophthalmologic diseases. Corcept leads the field in the research and development of selective glucocorticoid receptor (GR) antagonists, having discovered more than 500 proprietary molecules since being founded in 1998. C...
    we are leading the discovery and development of drugs that modulate the effects of cortisol Cortisol dysregulation plays an important role in a variety of endocrine, metabolic, oncologic, psychiatric, and ophthalmologic diseases. Corcept leads the field in the research and development of selective glucocorticoid receptor (GR) antagonists, having discovered more than 500 proprietary molecules since being founded in 1998. Corcept is committed to improving patient lives through the discovery and development of drugs that address serious unmet medical needs related to excess cortisol activity.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Corcept TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    149 Commonwealth Drive Menlo Park, CA 94025
    Telephone
    Telephone
    650-327-3270
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.corcept.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/corcept-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Scott+Scott Law Firm Alerts Investors To Investigation in Case
    Scott+Scott Law Firm Alerts Investors To Investigation in Case

    09 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-09/scottplusscott-attorneys-at-law-llp-reminds-investors-of-its-investigation-into-corcept-therapeutics-in

    PHARMIWEB
    09 Jan 2026
    Share Share
    Corcept Gets Complete Response Letter For Relacorilant
    Corcept Gets Complete Response Letter For Relacorilant

    31 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251231309474/en/Corcept-Receives-Complete-Response-Letter-for-Relacorilant-as-a-Treatment-for-Patients-with-Hypercortisolism

    BUSINESSWIRE
    31 Dec 2025
    Share Share
    Corcept Therapeutics Unveils Q3 Financials Result
    Corcept Therapeutics Unveils Q3 Financials Result

    04 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251104775200/en/Corcept-Therapeutics-Announces-Third-Quarter-Financial-Results-Oncology-Development-Programs-and-Provides-Corporate-Update

    BUSINESSWIRE
    04 Nov 2025
    Share Share
    Corcept Therapeutics To Report Q3 Financials, Update And Host
    Corcept Therapeutics To Report Q3 Financials, Update And Host

    28 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251028383789/en/Corcept-Therapeutics-to-Announce-Third-Quarter-Financial-Results-Provide-Corporate-Update-and-Host-Conference-Call

    BUSINESSWIRE
    28 Oct 2025
    Share Share
    Corcept’s Relacorilant Benefits PARPi-Treated Ovarian Cancer
    Corcept’s Relacorilant Benefits PARPi-Treated Ovarian Cancer

    19 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251019109551/en/Corcept-Presents-ESMO-2025-Late-Breaker-Relacorilant-Demonstrates-Benefit-in-Patients-with-Platinum-Resistant-Ovarian-Cancer-with-Prior-PARP-Inhibitor-Treatment

    BUSINESSWIRE
    19 Oct 2025
    Share Share
    Corcept Seeks EMA Approval For Relacorilant
    Corcept Seeks EMA Approval For Relacorilant

    14 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251014154513/en/Corcept-Submits-Marketing-Authorization-Application-to-European-Medicines-Agency-for-Relacorilant-as-a-Treatment-for-Patients-with-Platinum-Resistant-Ovarian-Cancer

    BUSINESSWIRE
    14 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search